BSE filing, NSE: CENTUM. Summary written from the filing by ALFA Finder's alert engine.
Centum Electronics Ltd: key numbers
- Share price
- ₹4,013.00
- Market cap
- ₹5,924 Cr
- Revenue (annual)
- ₹962.7 Cr
- Net profit (annual)
- ₹-46.65 Cr
- P/E (TTM)
- 119.4×Sector 36.4×
- Promoter holding
- 46.81%-0.01% QoQ
- FII holding
- 3.73%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Centum Electronics Ltd
All →Centum Electronics Board Meeting Date
Centum Electronics scheduled its Board meeting for November 4, 2026, to approve Q2/H1 FY27 results. An earnings call follows on November 5.
Centum Electronics Investor Presentation: Key Takeaways
Centum Electronics delivered Q1-FY27 standalone revenue of INR 2,048 Mn with 11.28% EBITDA margin, driven by its dual EMS-BTS model.
Centum Electronics Credit Rating
CARE Ratings upgraded Centum Electronics' bank facilities to CARE BBB+ Stable/CARE A2. This revision reflects the company's exit from loss-making overseas subsidiaries and growing order book.
Centum Electronics Capital Structure Change
Designated person Vinod Srinivasrao Chippalkatti sold 309 equity shares of Centum Electronics Ltd via market sale, valued at Rs. 13.43 Lakhs.
- Value
- ₹0.13 Cr
Centum Electronics Other Announcement
A designated person sold 309 shares of Centum Electronics Ltd, valued at Rs. 0.13 Crore, through a market transaction.
- Value
- ₹0.13 Cr
Centum Electronics Bags ₹30.5 Cr Order
Centum Electronics secured an export order from a global OEM for electronic systems. The contract, valued at ₹30.5 Crore, will be executed over seven months.
- Value
- ₹30.50 Cr
- Execution
- 7 months
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.